Kane Biotech, Inc. (KNE.V)
0.025
0.00 (0.00%)
CAD |
TSXV |
Aug 25, 15:30
Kane Biotech EPS Diluted (Quarterly) : -0.0039 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.0039 |
| September 30, 2025 | -0.0036 |
| June 30, 2025 | -0.0021 |
| March 31, 2025 | -0.0081 |
| December 31, 2024 | 0.0016 |
| September 30, 2024 | -0.0051 |
| June 30, 2024 | -0.0089 |
| March 31, 2024 | -0.0106 |
| September 30, 2023 | -0.0109 |
| June 30, 2023 | -0.007 |
| March 31, 2023 | -0.0096 |
| December 31, 2022 | -0.007 |
| September 30, 2022 | -0.0083 |
| June 30, 2022 | -0.0077 |
| March 31, 2022 | -0.0097 |
| December 31, 2021 | -0.0111 |
| September 30, 2021 | -0.0133 |
| June 30, 2021 | -0.0081 |
| March 31, 2021 | -0.0084 |
| December 31, 2020 | -0.0075 |
| September 30, 2020 | -0.0095 |
| June 30, 2020 | -0.0046 |
| March 31, 2020 | -0.0131 |
| December 31, 2019 | -0.0114 |
| September 30, 2019 | -0.0099 |
| Date | Value |
|---|---|
| June 30, 2019 | 0.0208 |
| March 31, 2019 | -0.0082 |
| December 31, 2018 | -0.0084 |
| September 30, 2018 | -0.0122 |
| June 30, 2018 | -0.0086 |
| March 31, 2018 | -0.0109 |
| December 31, 2017 | -0.01 |
| September 30, 2017 | -0.0108 |
| June 30, 2017 | -0.02 |
| March 31, 2017 | -0.01 |
| December 31, 2016 | -0.011 |
| September 30, 2016 | -0.0136 |
| June 30, 2016 | -0.0188 |
| March 31, 2016 | -0.0212 |
| December 31, 2015 | -0.0176 |
| September 30, 2015 | -0.016 |
| June 30, 2015 | -0.0136 |
| March 31, 2015 | -0.0199 |
| December 31, 2014 | -0.0186 |
| September 30, 2014 | -0.0182 |
| June 30, 2014 | -0.0438 |
| March 31, 2014 | -0.0165 |
| December 31, 2013 | -0.007 |
| September 30, 2013 | -0.0184 |
| June 30, 2013 | -0.0182 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Quest PharmaTech, Inc. | 0.0201 |
| BriaCell Therapeutics Corp. | -1.354 |
| Vaxil Bio Ltd. | -0.0269 |
| Waverley Pharma, Inc. | -0.0031 |
| Goldcoast Resource Corp. | -0.0725 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.7148M |
| Revenue (Quarterly) | 0.0432M |
| Total Expenses (Quarterly) | 0.758M |
| Enterprise Value | 6.978M |
| Gross Profit Margin (Quarterly) | -53.01% |
| Profit Margin (Quarterly) | -1.65K% |
| Earnings Yield | -70.80% |
| Normalized Earnings Yield | -71.60 |